Scholarlink

Purpose <p>This study aims to elucidate the classification, clinical presentation, follow-up, and treatment outcomes of elderly patients diagnosed with infectious keratitis.</p> Methods <p>This retrospective single-center analysis, conducted at a tertiary ophthalmology center (Ege University Medical Faculty Hospital, Department of Ophthalmology, Izmir, Turkiye), included 317 patients aged ≥ 60&#xa0;years diagnosed with infectious keratitis between January 2012 and January 2025. Microbiological culture results, clinical course, comorbidities, treatments, and outcomes were evaluated.</p> Results <p>The female-to-male ratio was 0.89 and the mean age was 72.1 ± 7.23&#xa0;years (range: 60–96&#xa0;years). Positive culture results were identified in 128 (40.4%) of 317 patients, with 81 (63.3%) bacterial and 47 (36.7%) fungal infections. <i>Streptococcus pneumoniae</i> (29.7%) was the most common pathogen. Most lesions were central/paracentral (89.9%) and single (79.2%). The mean best-corrected visual acuity (BCVA) improved from 2.33 ± 0.99 LogMAR to 1.99 ± 1.08 LogMAR (95% CI, 0.15–0.53; paired-samples t test, <i>p</i> &lt; 0.001). Most patients (76.3%) responded favorably to empirical treatment. Recurrence occurred in 34 patients, 22 required corneal transplantation, and 9 underwent evisceration. Dry eye (43.8%) and systemic immunosuppression (36.9%) were the most common comorbidities.</p> Conclusion <p>In the present study, differing from some others that report coagulase-negative <i>Staphylococci</i> as the predominant agent in elderly infectious keratitis patients, the most common pathogen was <i>Streptococcus pneumoniae</i>. This finding highlights potential regional or methodological differences. The presence of dry eye and systemic immunosuppression significantly influenced unfavorable outcomes, emphasizing the importance of addressing these risk factors. Tailored treatment strategies may improve outcomes in this population.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A thirteen-year tertiary centre experience with infectious keratitis in the elderly population

  • 期刊论文

  • 发表日期：

    2026年3月2日

查看全文
  • Emre Karahan,
  • Ozlem Barut Selver,
  • Sohret Aydemir,
  • Dilek Yesim Metin,
  • Melis Palamar

摘要

Purpose

This study aims to elucidate the classification, clinical presentation, follow-up, and treatment outcomes of elderly patients diagnosed with infectious keratitis.

Methods

This retrospective single-center analysis, conducted at a tertiary ophthalmology center (Ege University Medical Faculty Hospital, Department of Ophthalmology, Izmir, Turkiye), included 317 patients aged ≥ 60 years diagnosed with infectious keratitis between January 2012 and January 2025. Microbiological culture results, clinical course, comorbidities, treatments, and outcomes were evaluated.

Results

The female-to-male ratio was 0.89 and the mean age was 72.1 ± 7.23 years (range: 60–96 years). Positive culture results were identified in 128 (40.4%) of 317 patients, with 81 (63.3%) bacterial and 47 (36.7%) fungal infections. Streptococcus pneumoniae (29.7%) was the most common pathogen. Most lesions were central/paracentral (89.9%) and single (79.2%). The mean best-corrected visual acuity (BCVA) improved from 2.33 ± 0.99 LogMAR to 1.99 ± 1.08 LogMAR (95% CI, 0.15–0.53; paired-samples t test, p < 0.001). Most patients (76.3%) responded favorably to empirical treatment. Recurrence occurred in 34 patients, 22 required corneal transplantation, and 9 underwent evisceration. Dry eye (43.8%) and systemic immunosuppression (36.9%) were the most common comorbidities.

Conclusion

In the present study, differing from some others that report coagulase-negative Staphylococci as the predominant agent in elderly infectious keratitis patients, the most common pathogen was Streptococcus pneumoniae. This finding highlights potential regional or methodological differences. The presence of dry eye and systemic immunosuppression significantly influenced unfavorable outcomes, emphasizing the importance of addressing these risk factors. Tailored treatment strategies may improve outcomes in this population.